Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
86.47
+0.51 (0.59%)
May 29, 2026, 4:00 PM EDT - Market closed
Edwards Lifesciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,304 | 6,068 | 5,440 | 5,010 | 4,464 | 5,233 | |
Revenue Growth (YoY) | 14.15% | 11.55% | 8.57% | 12.23% | -14.69% | 19.29% |
Cost of Revenue | 1,395 | 1,334 | 1,118 | 978.4 | 723.7 | 1,249 |
Gross Profit | 4,908 | 4,733 | 4,322 | 4,032 | 3,740 | 3,984 |
Selling, General & Admin | 2,142 | 2,085 | 1,789 | 1,583 | 1,358 | 1,494 |
Research & Development | 1,088 | 1,079 | 1,053 | 962.9 | 843.6 | 903.1 |
Other Operating Expenses | 331.7 | 304.8 | 101.1 | 177.3 | 40.7 | -103.5 |
Total Operating Expenses | 3,561 | 3,469 | 2,943 | 2,723 | 2,242 | 2,293 |
Operating Income | 1,347 | 1,264 | 1,379 | 1,309 | 1,498 | 1,690 |
Interest Income | - | 168.8 | 120.3 | 67.2 | 35.5 | 17.4 |
Interest Expense | - | -20.4 | -19.8 | -17.6 | -19.2 | -18.4 |
Other Non-Operating Income (Expense) | -49 | -139.7 | 68.9 | 13.9 | 4.8 | 12.7 |
Total Non-Operating Income (Expense) | -49 | 8.7 | 169.4 | 63.5 | 21.1 | 11.7 |
Pretax Income | 1,298 | 1,273 | 1,548 | 1,372 | 1,520 | 1,702 |
Provision for Income Taxes | 224.9 | 216.9 | 152.1 | 152.4 | 195.5 | 198.9 |
Net Income | 1,096 | 1,074 | 4,175 | 1,402 | 1,522 | 1,503 |
Minority Interest in Earnings | -2.5 | -4.1 | -4.9 | -3 | - | - |
Earnings From Discontinued Operations | 20.6 | 13.4 | 2,774 | 179.4 | 197.9 | - |
Net Income to Common | 1,096 | 1,074 | 4,175 | 1,402 | 1,522 | 1,503 |
Net Income Growth | -73.78% | -74.28% | 197.68% | -7.85% | 1.25% | 82.55% |
Shares Outstanding (Basic) | 583 | 585 | 598 | 607 | 619 | 623 |
Shares Outstanding (Diluted) | 584 | 586 | 599 | 609 | 624 | 631 |
Shares Change (YoY) | -1.87% | -2.25% | -1.66% | -2.37% | -1.11% | -0.11% |
EPS (Basic) | 1.89 | 1.84 | 6.98 | 2.31 | 2.46 | 2.41 |
EPS (Diluted) | 1.88 | 1.83 | 6.97 | 2.30 | 2.44 | 2.38 |
EPS Growth | -73.14% | -73.75% | 203.04% | -5.74% | 2.52% | 83.08% |
Shares Outstanding | 577 | 580.7 | 588.6 | 601.1 | 608.3 | 624.1 |
Free Cash Flow | 1,090 | 1,335 | 289.9 | 642.8 | 973.6 | 1,406 |
Free Cash Flow Growth | -18.39% | 360.50% | -54.90% | -33.98% | -30.77% | 117.26% |
Free Cash Flow Per Share | 1.87 | 2.28 | 0.48 | 1.05 | 1.56 | 2.23 |
Gross Margin | 77.87% | 78.01% | 79.46% | 80.47% | 83.79% | 76.13% |
Operating Margin | 21.37% | 20.84% | 25.35% | 26.13% | 33.57% | 32.30% |
Profit Margin | 17.02% | 17.40% | 25.66% | 24.35% | 29.66% | 28.73% |
FCF Margin | 17.28% | 22.00% | 5.33% | 12.83% | 21.81% | 26.88% |
EBITDA | 1,508 | 1,421 | 1,534 | 1,454 | 1,638 | 1,825 |
EBITDA Margin | 23.92% | 23.42% | 28.20% | 29.02% | 36.69% | 34.88% |
EBIT | 1,347 | 1,264 | 1,379 | 1,309 | 1,498 | 1,690 |
EBIT Margin | 21.37% | 20.84% | 25.35% | 26.13% | 33.57% | 32.30% |
Effective Tax Rate | 17.33% | 17.04% | 9.82% | 11.10% | 12.87% | 11.69% |